查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1931230

髋关节持续被动运动装置市场按操作模式、装置类型、最终用户、通路和应用划分－全球预测，2026-2032年

Hip Continuous Passive Motion Device Market by Operation Mode, Device Type, End User, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年髋关节持续被动运动装置市值为 3.8487 亿美元，预计到 2026 年将成长至 4.0903 亿美元，年复合成长率为 5.69%，到 2032 年将达到 5.6727 亿美元。

主要市场统计数据
基准年 2025 3.8487亿美元
预计年份：2026年 4.0903亿美元
预测年份：2032年 5.6727亿美元
复合年增长率 (%) 5.69%

持续被动式髋关节运动装置在现代医疗流程中的地位：满足临床需求、提高营运效率并应对不断变化的患者期​​望

本文旨在将髋关节持续被动运动装置定位于当今以加速復健、降低併发症发生率和提高患者自主性为核心的医疗环境中。临床医生和护理管理人员日益寻求能够改善术后活动能力并最大限度减少资源负担的干预措施，而控制关节运动的装置是实现这些目标的关键。因此，从装置开发商到医疗服务机构的相关人员都在修订通讯协定、采购标准和病患教育方案，将运动疗法纳入围手术全期和復健流程的核心组成部分。

临床优先事项、数位化应用和实证采购如何重新定义持续被动髋关节运动装置的应用和创新

临床压力、技术成熟度和以患者为中心的护理模式的融合，正在推动该领域的变革。改进的围手术全期通讯协定强调早期活动，以缩短住院时间并降低併发症风险。这提升了行动辅助设备在促进标准化復健方面的作用。同时，可程式设计控制系统和使用者介面的进步使得治疗方案的发展更加精准，而低功耗电子元件和模组化设计则拓展了其在门诊和家庭环境中的应用范围。

评估2025年关税调整对美国髋关节持续被动式运动装置的采购、定价和供应链韧性的影响

2025年实施的关税调整带来的累积影响，增加了设备采购、成本结构和策略供应链规划的复杂性。对于依赖跨境零件采购或成品进口的製造商和经销商，关税制度的改变迫使他们重新评估供应商合约、到岸成本计算和定价策略，以维持利润率和保持竞争力。这些趋势促使他们进行短期库存调整和长期供应商多元化倡议。

以细分市场主导的策略，加速产品普及：协调营运模式、终端用户需求、通路、设备架构和临床应用。

关键細項分析揭示了产品属性、分销管道和临床方面的差异如何塑造竞争格​​局和采购需求。从操作模式来看，区分非可程式设计设备和可程式设计设备颇具启发意义。非可程式设计设备通常优先考虑便利性和低成本，并以交流电或电池供电的形式提供，以方便携带。而可程式设计设备则强调个人化治疗方案和透过数位和机械介面实现的高阶控制，进而影响临床医生的偏好和报销管道。

区域通路和商业化工具：美洲、欧洲、中东和非洲以及亚太市场的产品和证据管道策略的区域优化

区域洞察凸显了全球主要市场在需求驱动因素、法规环境和商业化管道方面的差异。在美洲，医疗保健服务以整合式医院系统、门诊手术的成长以及活性化的居家医疗市场为重点，其中报销机制和采购方整合会影响筹资策略。该地区偏好那些能够展现营运效率和显着术后疗效的医疗器械，而与大型医疗保健系统建立策略联盟往往能够显着加速产品的普及。

透过实证医疗设备、灵活的分销策略和敏捷的生产能力实现差异化竞争，从而获得更强大的市场地位。

对主要企业的深入分析凸显了产品设计、临床证据、通路布局和服务交付的策略选择如何决定市场定位。行业领导者透过将数据收集和远端监控功能整合到设备中来实现差异化，从而支援疗效评估并透过服务合约创建持续性收入模式。同时，其他企业则专注于模组化、低成本的平台设计，以促进租赁和所有权模式的可扩展性，从而渗透到以价值为导向的管道，例如独立门诊中心和直接面向消费者的居家医疗。

促进髋关节持续运动装置推广应用、确保报销以及建构稳健的供应和分销模式的实用策略措施

针对行业领导者的具体建议着重于使产品蓝图与支付方的期望、临床工作流程和病患体验要求保持一致。首先，应优先将实证实践融入产品开发，设计前瞻性临床项目和实用性研究，以证明产品的功能性结果和成本效益，从而为采购和报销谈判提供支援。其次，应透过直觉的介面和可靠的电源选项来提高设备的易用性，从而扩大其在家庭护理中的适用范围，并减轻临床人员的负担。

采用严谨的混合方法调查方法，结合相关人员访谈、临床文献综述、监管分析和横断面细分，以支持策略洞察。

我们的调查方法整合了多方面的证据基础、相关人员访谈和定性分析，以得出可靠的实用结论。主要研究包括对临床医生、復健专业人员、医院采购人员、医疗设备製造商和分销合作伙伴进行结构化访谈，以收集有关临床效用、购买动机和营运限制的第一手资讯。透过这些访谈，我们确定了产品设计、分销管道特征和证据要求的关键主题。

整合策略要务：证据、设计和商业性敏捷性表明，髋关节持续被动运动装置领域的长期成功将取决于哪些因素。

总之，我们总结以下核心讯息：髋关节持续被动运动装置正透过技术改进、实证检验和分销创新，从一种小众的术后辅助器具转变为现代復健策略的重要组成部分。相关人员，最有可能抓住最具吸引力的机会。关税趋势、区域监管差异以及不断变化的支付方期望之间的相互作用，凸显了建立适应性强的供应链和製定本地化商业化计划的必要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依操作模式分類的髋关节持续被动运动装置市场

  • 非可程式设备
    • 交流电源
    • 电池供电
  • 可程式装置
    • 数位介面
    • 机械接口

9. 依设备类型分類的髋关节持续被动运动装置市场

  • 家用设备
  • 医院用设备

10. 依最终使用者分類的髋关节持续被动运动装置市场

  • 门诊手术中心
  • 居家医疗
  • 医院

第十一章 髋关节持续被动式运动装置市场（依通路划分）

  • 离线
  • 在线的

12. 按应用分類的髋关节持续被动式运动装置市场

  • 慢性期管理
    • 骨关节炎管理
    • 关节炎管理
  • 损伤康復
    • 运动伤害
    • 创伤性损伤
  • 术后康復
    • 髋关节置换术
    • 全髋关节置换术

13. 髋关节持续被动式运动装置市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 髋关节持续被动式运动装置市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国髋关节持续被动式运动装置市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国持续被动髋关节运动装置市场

第十七章 中国髋关节连续被动式运动装置市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • BMS
  • Breg, Inc.
  • Chattanooga International
  • Chirag Electronics Pvt. Ltd.
  • CONMED Corporation
  • DePuy Synthes
  • DJO Global, Inc.
  • HMS Medical Systems
  • India Medico Instruments
  • Kinetec
  • Medline Industries, LP
  • NC Medical Systems
  • OPED
  • OrthoRehab, Inc.
  • Physio Care Devices
  • Prasaditi Medical Equipments
  • Rimec
  • Smith & Nephew PLC
  • Stryker Corporation
  • Technomed Electronics
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-7B550E008DD2

The Hip Continuous Passive Motion Device Market was valued at USD 384.87 million in 2025 and is projected to grow to USD 409.03 million in 2026, with a CAGR of 5.69%, reaching USD 567.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 384.87 million
Estimated Year [2026] USD 409.03 million
Forecast Year [2032] USD 567.27 million
CAGR (%) 5.69%

Positioning hip continuous passive motion devices within modern care pathways to address clinical needs, operational efficiency, and evolving patient expectations

The introduction frames the contemporary relevance of hip continuous passive motion devices within a healthcare environment that prizes accelerated recovery, reduced complication rates, and enhanced patient autonomy. Clinicians and care managers increasingly seek interventions that improve postoperative mobility while minimizing resource burden, and devices that deliver controlled joint movement are central to these objectives. Consequently, stakeholders from device innovators to care delivery organizations are recalibrating protocols, procurement criteria, and patient education to incorporate motion therapy as a core component of perioperative and rehabilitative pathways.

Against this backdrop, the device landscape is evolving along multiple dimensions: technological refinement of control interfaces, diversification of power sources to enable true home use, and reorientation of distribution channels to meet the expectations of digitally enabled patients. Transitioning clinical practice patterns and payer scrutiny are raising the bar for evidence generation, usability, and cost-effectiveness. Therefore, this introduction establishes the device category as an intersection of clinical utility, engineering design, and commercial strategy, and sets the stage for a deeper examination of market forces, regulatory influences, and segmentation-driven opportunities that follow.

How clinical priorities, digital enablement, and evidence-driven procurement are redefining adoption and innovation in hip continuous passive motion devices

Transformative shifts in the landscape are driven by converging pressures from clinical practice, technology maturation, and patient-centric care models. Enhanced perioperative protocols emphasize early mobilization to reduce length of stay and lower complication risks, which elevates the role of motion devices as facilitators of standardized rehabilitation. Concurrently, advances in programmable control systems and user interfaces are enabling more precise therapy regimens, while lower-power electronics and modular designs broaden the feasibility of outpatient and home-based applications.

Moreover, reimbursement frameworks and hospital procurement are increasingly tied to demonstrable outcomes, compelling manufacturers to invest in clinical studies and integrate data capture capabilities into their devices. This shift encourages partnerships between clinical stakeholders and device developers to validate efficacy and track long-term functional outcomes. Digital enablement and remote monitoring are also redefining clinician oversight of at-home therapy, enabling adaptive protocols that respond to patient progress. Taken together, these shifts are reshaping adoption drivers, influencing product roadmaps, and creating new vectors for differentiation across design, service, and evidence generation.

Assessing how 2025 tariff adjustments altered sourcing, pricing, and supply chain resilience for hip continuous passive motion devices in the United States

The cumulative impact of tariff changes in the United States during 2025 introduced a layer of complexity to device sourcing, cost structures, and strategic supply chain planning. For manufacturers and distributors that rely on cross-border component procurement or finished goods importation, altered tariff regimes necessitated reassessments of supplier contracts, landed cost calculations, and pricing strategies to preserve margin and maintain competitive parity. These developments prompted near-term inventory adjustments and longer-term supplier diversification initiatives.

In response, manufacturers accelerated evaluation of domestic assembly options and regional manufacturing partnerships to mitigate exposure and reduce logistics lead times, while channel partners adjusted contract terms to absorb or pass through incremental costs depending on competitive positioning. At the same time, clinical purchasers and hospital supply chain teams heightened scrutiny on total cost of ownership and sought bundled service agreements that offset potential price increases. The tariff landscape therefore acted as a catalyst for more resilient sourcing strategies, reinforced the strategic importance of value-based contracting, and encouraged stakeholders to consider localization and vertical integration where feasible to protect continuity of supply and price stability.

Segment-driven strategies that align operation modes, end-user needs, distribution pathways, device architectures, and clinical applications to accelerate adoption

Key segmentation insights reveal how distinct product, channel, and clinical dimensions shape competitive dynamics and buyer requirements. When analyzing devices by operation mode, distinctions between non-programmable devices and programmable devices are instructive: non-programmable variants typically prioritize simplicity and lower cost and are available as AC-powered units and battery-operated units that support portability, while programmable devices emphasize tailored regimens and sophisticated control through digital interfaces or mechanical interfaces, influencing clinician preference and reimbursement pathways.

End-user segmentation further differentiates requirements across ambulatory surgical centers, home healthcare, and hospitals. Ambulatory surgical centers encompass both hospital-owned centers and independent centers with divergent procurement cycles and capital constraints. Home healthcare settings include direct-to-consumer rental models and professional home healthcare providers that demand robust patient support and remote monitoring. Hospitals split into general hospitals and orthopedic specialty hospitals, each imposing unique clinical workflows, volume expectations, and evidence thresholds.

Distribution channel dynamics are equally consequential, spanning direct sales, e-commerce platforms, and third-party distributors. Direct sales often route through group purchasing organization arrangements and original equipment manufacturer sales teams; e-commerce includes manufacturer online stores alongside third-party online platforms; third-party distributors range from full-line distributors to those specialized in devices. Device type delineations between home-based devices and hospital-based devices inform design trade-offs where home-based options can be owned or rental models, and hospital-based formats vary between free-standing and table-top mounted units. Finally, application segmentation across chronic management, injury rehabilitation, and postoperative rehabilitation frames clinical value propositions: chronic management addresses degenerative joint disease and osteoarthritis, injury rehabilitation covers sports and traumatic injuries, and postoperative rehabilitation encompasses hip resurfacing and total hip replacement pathways. Collectively, these segmentation lenses illuminate targeted product development, tailored go-to-market approaches, and differentiated service models that resonate with specific buyer cohorts.

Regional pathways and commercialization levers that tailor product, evidence, and channel strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional insights underscore differentiated demand drivers, regulatory environments, and commercialization pathways across major global markets. In the Americas, healthcare delivery emphasizes integrated hospital systems, outpatient surgical growth, and an increasingly active homecare market where reimbursement and purchaser consolidation influence procurement strategies. This region tends to favor devices that demonstrate operational efficiency and clear postoperative outcome benefits, and strategic partnerships with large health systems can materially accelerate adoption.

In Europe, Middle East & Africa, fragmented reimbursement systems and diverse regulatory requirements create both challenges and opportunities; national-level health technology assessments and device registration processes influence launch sequencing, while private-sector growth in certain urban markets supports earlier uptake of innovative programmable devices. Stakeholders in this geography often prioritize robust clinical evidence and localized support infrastructure to ensure clinician confidence and patient adherence.

Asia-Pacific presents a dynamic mix of high-volume public hospital systems, expanding private care, and growing consumer demand for at-home solutions. Rapid urbanization and investments in outpatient services are enabling new distribution models, while local manufacturing and regulatory acceleration in several markets can shorten commercialization timelines. Each region therefore requires calibrated market-entry tactics, evidence generation strategies, and channel partnerships that reflect local reimbursement, clinical practice, and patient behavior patterns.

Competitive differentiation through evidence-enabled devices, adaptive distribution strategies, and manufacturing agility to strengthen market positioning

Insights on leading companies highlight how strategic choices in product design, clinical evidence, channel orchestration, and service delivery determine market positioning. Industry leaders are differentiating by integrating data capture and remote monitoring capabilities into devices to support outcome measurement and to create recurring revenue models through service contracts. Others concentrate on modular, low-cost platform designs that facilitate scale across rental and owned models, enabling penetration of value-conscious channels such as independent ambulatory centers and direct-to-consumer homecare.

Competitive advantage also emerges from distribution sophistication: some firms emphasize direct relationships with health systems and group purchasing organizations to secure preferred-supplier status, while others expand e-commerce capabilities and partnerships with specialized distributors to reach homecare and smaller hospital segments. Strategic collaborations with rehabilitation providers and payers are being used to generate real-world evidence and to support reimbursement narratives. Finally, investments in manufacturing flexibility and regional partnerships are enabling faster response to tariff dynamics and shifting demand, reinforcing supply continuity and supporting localized go-to-market strategies.

Practical strategic moves to boost adoption, secure reimbursement, and build resilient supply and distribution models for continuous motion hip devices

Actionable recommendations for industry leaders focus on aligning product roadmaps with payer expectations, clinical workflows, and patient experience imperatives. First, prioritize integration of evidence generation into product development by designing prospective clinical programs and pragmatic studies that demonstrate functional outcomes and cost-effectiveness, thereby supporting procurement and reimbursement discussions. Second, enhance device usability through intuitive interfaces and reliable power options to broaden suitability for home-based therapy and reduce the burden on clinical staff.

Third, diversify distribution by balancing direct health system engagement with scalable e-commerce models and selective third-party distributor relationships to optimize reach across hospitals, ambulatory centers, and homecare. Fourth, fortify supply chains through regional manufacturing partnerships or flexible contract manufacturing to mitigate tariff exposure and logistics disruption. Finally, develop service-led revenue streams that include rentals, remote monitoring, and support packages to create predictable lifetime value and to differentiate offerings on post-sale performance and adherence support. Executing these recommendations will accelerate adoption, strengthen commercial resilience, and improve patient outcomes.

Rigorous mixed-methods research combining stakeholder interviews, clinical literature review, regulatory analysis, and cross-sectional segmentation to underpin strategic findings

The research methodology combines a multi-source evidence base, stakeholder interviews, and qualitative analysis to ensure robust and actionable conclusions. Primary research included structured interviews with clinicians, rehabilitation specialists, hospital procurement leaders, device manufacturers, and distribution partners to capture firsthand perspectives on clinical utility, purchasing drivers, and operational constraints. These conversations informed the identification of key themes in product design, channel dynamics, and evidence needs.

Secondary analysis synthesized regulatory guidance, clinical literature, and publicly available policy documentation to contextualize clinical adoption barriers and reimbursement considerations. Comparative analysis across operation modes, end-user segments, distribution channels, device types, and applications enabled consistent mapping of needs to product and go-to-market solutions. Cross-validation with supply chain and manufacturing data provided additional rigor on sourcing and tariff-related implications. Throughout, the approach emphasized triangulation of insights to reduce bias and to highlight implications that are directly relevant to decision-makers seeking to prioritize investments and actions.

Synthesis of strategic imperatives showing how evidence, design, and commercial agility will determine long-term success in the hip continuous passive motion device category

The conclusion synthesizes the central narrative: hip continuous passive motion devices are transitioning from niche postoperative adjuncts to integral components of modern rehabilitation strategies through technological refinement, evidence-based validation, and distribution innovation. Stakeholders that align product design with clinician workflow, demonstrate measurable outcomes, and create flexible commercial models will capture the most compelling opportunities. The interplay of tariff dynamics, regional regulatory variation, and evolving payer expectations underscores the need for adaptable supply chains and localized commercialization plans.

Looking ahead, the category's future momentum will hinge on its ability to deliver both clinical benefits and operational value, to scale service-led models that enhance adherence, and to partner effectively with care providers and payers to embed devices within standardized care pathways. Firms that combine compelling clinical evidence, user-centric design, and multi-channel distribution will be best positioned to translate innovation into sustained clinical impact and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hip Continuous Passive Motion Device Market, by Operation Mode

  • 8.1. Non-Programmable Devices
    • 8.1.1. AC-Powered
    • 8.1.2. Battery-Operated
  • 8.2. Programmable Devices
    • 8.2.1. Digital Interface
    • 8.2.2. Mechanical Interface

9. Hip Continuous Passive Motion Device Market, by Device Type

  • 9.1. Home-Based Devices
  • 9.2. Hospital-Based Devices

10. Hip Continuous Passive Motion Device Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals

11. Hip Continuous Passive Motion Device Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Hip Continuous Passive Motion Device Market, by Application

  • 12.1. Chronic Management
    • 12.1.1. Degenerative Joint Disease Management
    • 12.1.2. Osteoarthritis Management
  • 12.2. Injury Rehabilitation
    • 12.2.1. Sports Injuries
    • 12.2.2. Traumatic Injuries
  • 12.3. Postoperative Rehabilitation
    • 12.3.1. Hip Resurfacing
    • 12.3.2. Total Hip Replacement

13. Hip Continuous Passive Motion Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hip Continuous Passive Motion Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hip Continuous Passive Motion Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Hip Continuous Passive Motion Device Market

17. China Hip Continuous Passive Motion Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. BMS
  • 18.6. Breg, Inc.
  • 18.7. Chattanooga International
  • 18.8. Chirag Electronics Pvt. Ltd.
  • 18.9. CONMED Corporation
  • 18.10. DePuy Synthes
  • 18.11. DJO Global, Inc.
  • 18.12. HMS Medical Systems
  • 18.13. India Medico Instruments
  • 18.14. Kinetec
  • 18.15. Medline Industries, LP
  • 18.16. NC Medical Systems
  • 18.17. OPED
  • 18.18. OrthoRehab, Inc.
  • 18.19. Physio Care Devices
  • 18.20. Prasaditi Medical Equipments
  • 18.21. Rimec
  • 18.22. Smith & Nephew PLC
  • 18.23. Stryker Corporation
  • 18.24. Technomed Electronics
  • 18.25. Zimmer Biomet Holdings, Inc.
  • 18.26. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AC-POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AC-POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AC-POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY BATTERY-OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY BATTERY-OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY BATTERY-OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DIGITAL INTERFACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DIGITAL INTERFACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DIGITAL INTERFACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY MECHANICAL INTERFACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY MECHANICAL INTERFACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY MECHANICAL INTERFACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITAL-BASED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITAL-BASED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITAL-BASED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEGENERATIVE JOINT DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEGENERATIVE JOINT DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEGENERATIVE JOINT DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OSTEOARTHRITIS MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OSTEOARTHRITIS MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OSTEOARTHRITIS MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SPORTS INJURIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SPORTS INJURIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SPORTS INJURIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TRAUMATIC INJURIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TRAUMATIC INJURIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TRAUMATIC INJURIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HIP RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HIP RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY HIP RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 188. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 221. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 222. G7 HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 223. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 232. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 233. NATO HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY NON-PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY PROGRAMMABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY CHRONIC MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY INJURY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA HIP CONTINUOUS PASSIVE MOTION DEVICE MARKET SIZE, BY POSTOPERATIVE REHABILITATION, 2018-2032 (USD MILLION)